CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34+ cells

Blood

Volumn 95, Issue 2, 2000, Pages 453-460

  Rosenzwajg, Michelle ^b   Tailleux, Ludovic ^b   Gluckman, Jean Claude ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTINONIN; CASPASE 3; COLONY STIMULATING FACTOR 1; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVE SITE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

EID: 0034650948     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.2.453     Document Type: Article

References (58)

1. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 1992;360:258-261.
2. Reid CD, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyta-macrophage colony-stimulating laclor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol. 1992;149:2681-2688.
3. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol. 1992;52:274-281.
4. Rosenzwajg M, Canque B, Gluckman JC. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood. 1996;87: 535-544.
5. Strunk D, Rappersberger K, Egger C, et al. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood. 1996;87:1292-1302.
6. Rosenzwajg M, Camus S, Guigon M, Gluckman JC. The influence of Interleukine (IL)-4, IL-13 and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells. Exp Hematol. 1998;26:63-72.
7. Szabolcs P, Moore MA, Young JW. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol. 1995;154:5851-5861.
8. Caux C, Vanbervliet B, Massacrier C, et al. CD34+ hemalopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF alpha. J Exp Med. 1996;184:695-706.
9. Szabolcs P, Avigan D, Gezelter S, et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood. 1996;B7: 4520-4530.
10. Canque B, Camus S, Yagello M, Gluckman J. IL-4 and CD40 ligation affect differently the differentiation, maturation and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic precursors in vitro. J Leukoc Biol. 1998;64:235-244.
11. Canque B, Rosenzwajg M, Camus S, et al. The effect of in vitro human immunodeficiency virus infection on dendritic cell differentiation and function. Blood. 1996;88:4215-4228.
12. Shipp MA, Look AT. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood. 1993;82:1052-1070.
13. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J CHn Invest. 1989;83:1299-1307.
14. Hansen AS, Noren O, Sjöström H, Werdelin O. A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules. Eur J Immunol. 1993;23:2358-2364.
15. Larsen SL, Pedersen OL, Buus S, Stryhn A. J cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histcompatibility complex class II-bound peptides. J Exp Med. 1996; 184:183-189.
16. Amoscato AA, Prenovitz DA, Lotze M. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. J Immunol. 1998; 161:4023-4032.
17. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 1995;3:459-473.
18. Santiago-Schwarz F, Borrero M, Tucci J, Palaia T, Carsons SE. In vitro expansion of CD13+CD33+ dendritic cell precursors from multipotent progenitors is regulated by a discrete fas-mediated apoptotic schedule. J Leukoc Biol. 1997;62:493-502.
19. Marquez C, Trigueros C, Franco JM, et al. Identification of a common developmental pathway for thymic natural killer cells and dendritic cells. Blood. 1998;91:2760-2771.
20. Canque B, Rosenzwajg M, Camus S, et al. The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. Blood. 1996;88:4215-4228.
21. Canque B, Camus S, Yagello M, Gluckman J. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors. Stem Cells. 1998;16: 218-228.
22. Griffin JD, Ritz J, Beveridge RP, Lipton JM, Daley JF, Schlossman SF. Expression of My7 antigen on myeloid precursor cells. Int J Cell Cloning. 1983;1:33-48.
23. Lendeckel U, Wex T, Ittenson A, et al. Rapid mitogen-induced aminopeptidase N surface expression in human T cells is dominated by mechanisms independent of de novo protein biosynthesis. Immunobiology. 1997;197:55-69.
24. Xu Y, Lai LT, Gabrilove JL, Scheinberg DA. Antitumor activity of actinonin in vitro and in vivo. Clin Cancer Res. 1998;4:171-176.
25. Tieku S, Hooper NM. Inhibition of aminopeptidases N, A and W: a re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme, Biochem Pharmacol. 1992;44:1725-1730.
26. Amoscato AA, Alexander JW, Babcock GF. Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells. J Immunol. 1989;142:1245-1252.
27. Ashmun RA, Look AT. Metaloprotease activity of CD13/aminipeptidase N on the surface of human myeloid cells. Blood. 1990;75:462-469.
28. Favaloro EJ. CD-13 ('gp150'; aminopeptidase-N): co-expression on endothelial and haemopoietic cells with conservation of functional activity. Immunol Cell Biol, 1991;69:253-260.
29. Favaloro EJ, Browning T, Facey D. CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated. Exp Hematol. 1993;21:1695-1701.
30. Favaloro EJ, Bradstock KF, Kabral A, Grimsley P, Zowtyj H, Zola H. Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and nonhaemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33. Br J Haematol. 1988;69:163-171.
31. Kanayama N, Kajiwara Y, Goto J, et al. Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol. 1995;57:129-134.
32. van der Velden VH, Naber BA, van der Spoel P, Hoogsteden HC, Versnel MA. Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidasss. Cytokine. 1998;10:55-65.
33. Murata M, Kubota Y, Tanaka T, Iiada-Tanaka K, Takahara J, Irino S. Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells. Leukemia. 1994;8: 2188-2193.
34. Adams JM, Cory S. The Bcl-2 protein familly: arbiters of cell survival. Science. 1998;281:1322-1326.
35. Olweus J, Lund-Johansen F, Terstappen LW. CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells. Blood. 1995;85:2402-2413.
36. Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as 6 lymphoid potential: suppression of apoptosis and counteraction by TNF-alpha and TGF-beta. J Immunol. 1996;157:2953-2960.
37. Riemann D, Kehlen A, Langner J. CD13 - not just a marker in leukemia typing. Immunol Today. 1999;20:83-38.
38. Sawada K, Sato N, Notoya A, et al. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells. Blood, 1995;85:194-202.
39. Drexler HG. Classification of acute myeloid leukemias - a comparison of FAB and immunophenotyping. Leukemia. 1987;1:697-705.
40. Saito M, Kumagai M, Okazaki T, et al. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells. Leukemia. 1995;9:1508-1516.
41. Lendeckel U, Wex T, Reinhold D, et al. Induction of the membrane alanyl aminopeptidase gene and surlace expression in human T-cells by mitogenic activation. Biochem J. 1996;319:817-821.
42. Ansorge S, Schon E, Kunz D. Membrane-bound peptidases of lymphocytes: functional implications. Biomed Biochim Acta. 1991;50:799-807.
43. Ino K, Goto S, Kosaki A, et al. Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro. Biotherapy. 1991;3:351-357.
44. Aoyagi T, Yoshida S, Nakamura Y, Shigihara Y, Hamada M, Takeuchi T. Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. I. Taxonomy, production, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo). 1990;43:143-148.
45. O'Connell PJ, Gerkis V, d'Apice AJ. Variable O-glycosylation of CD13 (aminopeptidase N). J Biol Chem. 1991;266:4593-4597.
46. Cheng EH, Kirsch DG, Clem RJ, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 1997;278:1966-1968.
47. Menrad A, Speicher D, Wacker J, Herlyn M. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res. 1993;53:1450-1455.
48. Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer. 1993; 54:137-143.
49. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998;188:373-386.
50. Bhattacharya C, Manna SK, Samanta S, Gupta SK, Samanta AK. An aminopeptidase regulates LPS stimulated interleukin-8 receptor on the surface of human neutrophils. Indian J Biochem Biophys. 1997;34:214-219.
51. Markowicz S, Engleman EG. Granulocyte-macrophage colony-stimulating factor promotes differenciation and survival of human peripheral blood dendrilic cells in vitro. J Clin Invest. 1990;85:955-961.
52. Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med. 1987;166:1484-1498.
53. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109-1118.
54. Hottmann T, Faust J, Neubert K, Ansorge S. Dipeptidyl peptidase IV (CD26) and aminopeptidase N (CD13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett. 1993;336:61-64.
55. Shibuya K, Chiba S, Hino M, et al. Enhancing effect of ubenimex (bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation. Biomed Pharmacother. 1991;45:71-80.
56. Ino K, Goto S, Okamoto T, et al. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity. Jpn J Cancer Res. 1994;85:927-933.
57. Franco R, Valenzuela A, Lluis C, Blanco J. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol Rev. 1998; 161:27-42.
58. Morimoto C, Schlossman SF. The structure and function of CD26 in the T-cell immune response. Immunol Rev. 1998;161:55-70.